TY - CHAP M1 - Book, Section TI - Evaluation of Candidates with Current and/or Past Malignancies A1 - Nair, Gayatri A1 - Nair, Vinay A2 - Molmenti, Ernesto Pompeo PY - 2023 T2 - Molmenti’s Kidney and Pancreas Transplantation: Operative Techniques and Medical Management, 2e AB - Malignancy is one of the common causes of mortality and morbidity after kidney transplantation. Kidney transplant recipients have two to four times higher risk of cancer when compared to an age and gender-matched general population. The cumulative incidence of solid organ cancers after kidney transplantation is 4–5% after 5 years, 10% after 10 years, and >25% after 20 years. Differences in cancer risk depend on the cancer type for kidney transplant recipients. The most significant increase in cancer incidence among renal transplant recipients is seen with Kaposi sarcoma, non-melanoma skin cancers, lip cancer post-transplant lymphoproliferative disorders, and genitourinary cancers. It is essential to evaluate cancer risk in potential kidney transplant recipients to avoid organ transplantation in patients with a poor prognosis due to cancer progression and to avoid exacerbating the recurrence risk of a prior cancer. SN - PB - McGraw Hill CY - New York, NY Y2 - 2024/03/28 UR - accesssurgery.mhmedical.com/content.aspx?aid=1194178921 ER -